Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results Appointed director
|
Landos Biopharma, Inc. (LABP)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/30/2023 |
8-K
| Appointed a new director
Docs:
|
"LANDOS BIOPHARMA, INC. AMENDED AND RESTATED CERTIFICATE OF INCORPORATION Landos Biopharma, Inc., a corporation organized and existing under the laws of the State of Delaware , does hereby certify as follows: FIRST: The name of the Company is Landos Biopharma, Inc. SECOND: The Company was originally formed as a corporation organized under the jurisdiction of the State of Delaware on January 6, 2017. THIRD: This Amended and Restated Certificate of Incorporation has been duly adopted and approved by the Board of Directors of the Company. The Certificate of Incorporation was last amended and restated by the Amended and Restated Certificate of Incorporation on February 8, 2021. FOURTH: This Amended and Restated Certificate of Incorporation was approved by the holders of the requisite number of ...",
"Landos Biopharma Expands Board of Directors with Appointment of Alka Batycky, Ph.D. NEW YORK, May 30, 2023 –– Landos Biopharma, Inc. , a clinical-stage biopharmaceutical company developing novel, oral medicines for patients with autoimmune diseases, today announced the appointment of Alka Batycky, Ph.D. to its Board of Directors and Audit Committee. “Dr. Batycky is an accomplished biopharmaceutical executive and an important addition to Landos’ Board,” said Gregory Oakes, President and CEO of Landos. “Dr. Batycky has a proven track record, and we look forward to her contributions as we execute upon our focused strategy in immunology.” Dr. Batycky brings with her over 25 years of global drug development experience in the biopharmaceutical industry, spanning from ..." |
|
03/10/2022 |
8-K
| Quarterly results |
08/27/2021 |
8-K
| Quarterly results |
05/19/2021 |
8-K
| Quarterly results |
04/13/2021 |
8-K
| Quarterly results |
|
|